HomeAI · summaries
Storia in 19 fonti
Moderna y Merck anuncian el éxito de su vacuna contra el melanoma tras un ensayo con resultados prometedores
El tratamiento combina una estrategia diseñada según las mutaciones de cada tumor con una inmunoterapia que ayuda al organismo a reconocer y atacar las células cancerosas.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
en.mercopress.com
A personalized mRNA therapy passes a phase 3 melanoma trial for the first time
Pharmaceutical companies Merck, known as MSD outside the United States and Canada, and Moderna announced on Wednesday that their individualized neoantigen therapy, intismeran…
- ·
biopharmadive.com
Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma
At an interim data check, investigators of a key trial found the individualized mRNA treatment kept disease from returning and stopped its spread, sparking a surge in Moderna…
